QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics.

Front Aging Neurosci · 2022 · PMC9407039 · PMID 36034142

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Alzheimer intranasal rivastigmine CCD pharmacokinetics ex vivo optimization Taif University 10.13039/501100006261 Statistical analysis of particle size (Y1) It was observed that ( p < 0.05) for the model was highly significant and could predict the closest response value of PS.

also in 132,142 other papers

marginally insignificantno p-value reported

The p -value for lack of fit was found to be greater than 0.05, which makes it marginally insignificant.

also in 511 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.